General Office of the General Administration of the people's Republic of China solicits opinions on the administrative measures for imported medicinal materials (Revised Version)
-
Last Update: 2016-09-21
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: CFDA 2016-9-21 in order to further strengthen the supervision and management of imported medicinal materials, the State Food and Drug Administration organized the revision of the measures for the administration of imported medicinal materials (for Trial Implementation), drafted the measures for the administration of imported medicinal materials (for revision), and now solicited opinions from the public Please feedback the relevant opinions to the State Food and Drug Administration (drug and cosmetic registration administration department) by email before October 20, 2016 Contact: Wu Dianzhen email: wudz@cfda.gov.cn Annex: Administrative Measures for imported medicinal materials (Revised Version) General Office of food and Drug Administration September 19, 2016 Annex: Administrative Measures for imported medicinal materials (Revised Version) Docx
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
